Cytokines as potential biomarkers of liver toxicity

Sandrine Lacour1, Jean-Charles Gautier, Marc Pallardy

  • 1Aventis Pharma Drug Safety Evaluation, Centre de Recherche de Paris, 13 Quai Jules Guesde 94403, Vitry sur Seine, Paris, France. sandrine.lacour@aventis.com

Insights

Drug-induced liver injury can cause cell death, but immune system cytokines like tumor necrosis factor alpha (TNFα) may offer predictive biomarkers. These molecular mediators could help identify idiosyncratic liver toxicity not seen in pre-clinical studies.

Area of Science:

  • Hepatotoxicity and immunology
  • Drug-induced liver injury (DILI)
  • Molecular mechanisms of liver damage

Background:

  • Some drug classes cause liver toxicity not predicted by pre-clinical models.
  • Hepatotoxicity involves parenchymal cell death via necrosis and apoptosis.
  • Immune response mediators, including cytokines, are implicated in liver damage.

Purpose of the Study:

  • To review the role of cytokines in drug-induced liver injury (DILI).
  • To explore cytokine profiles as potential biomarkers for idiosyncratic human liver toxicity.
  • To investigate why rodent models may not predict human hepatotoxicity.

Main Methods:

  • Review of recent scientific data on drug-induced liver injury.
  • Analysis of the role of cytokines (TNFα, IL-1β, IL-6) in mediating hepatic response to xenobiotics.
  • Comparison of rodent and human hepatocyte responses to cytokines.

Main Results:

  • Pro-inflammatory cytokines are released during toxic liver injury.
  • Cytokine networks mediate hepatic responses to various xenobiotics.
  • Differences in cytokine response between rodent and human hepatocytes may explain unpredicted clinical toxicities.

Conclusions:

  • Cytokine fingerprints could serve as biomarkers for idiosyncratic liver toxicity.
  • Understanding cytokine roles may improve prediction of drug-induced liver injury.
  • Further research into cytokine changes in rodent models may reveal human toxicity mechanisms.

Related Concept Videos

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...
Liver Regeneration01:24

Liver Regeneration

The liver is an important organ in vertebrates that plays an essential role in metabolism. It is also responsible for storing and redistributing nutrients such as carbohydrates, fats, and vitamins in the body. Additionally, the liver releases bile salts which are critical for digesting food and eliminating toxic metabolites from the body.
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are large...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...